Plasma-Lyte 148 & Glucose 5% w/v solution for infusion Ireland - English - HPRA (Health Products Regulatory Authority)

plasma-lyte 148 & glucose 5% w/v solution for infusion

baxter holding b.v. - glucose monohydrate; sodium chloride; potassium chloride; magnesium chloride hexahydrate; sodium acetate trihydrate ; sodium gluconate - solution for infusion - 5 percent weight/volume - solutions affecting the electrolyte balance; electrolytes with carbohydrates

Plasma-Lyte 148 & Glucose 5% w/v solution for infusion Ireland - English - HPRA (Health Products Regulatory Authority)

plasma-lyte 148 & glucose 5% w/v solution for infusion

baxter healthcare limited - glucose monohydrate; sodium chloride; potassium chloride; magnesium chloride hexahydrate; sodium acetate trihydrate; sodium gluconate - solution for infusion - 5 percent weight/volume - solutions affecting the electrolyte balance; electrolytes with carbohydrates

Plasma-Lyte 148 & Glucose 5% infusion 500ml Viaflo bags United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

plasma-lyte 148 & glucose 5% infusion 500ml viaflo bags

baxter healthcare ltd - potassium chloride; sodium chloride; glucose monohydrate; sodium gluconate; magnesium chloride hexahydrate; sodium acetate trihydrate - infusion - 370mg/1litre ; 5.26gram/1litre ; 55gram/1litre ; 5.02gram/1litre ; 300mg/1litre ; 3.68gram/1litre

Plasma-Lyte 148 & Glucose 5% infusion 1litre Viaflo bags United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

plasma-lyte 148 & glucose 5% infusion 1litre viaflo bags

baxter healthcare ltd - glucose monohydrate; sodium chloride; sodium gluconate; potassium chloride; sodium acetate trihydrate; magnesium chloride hexahydrate - infusion - 55gram/1litre ; 5.26gram/1litre ; 5.02gram/1litre ; 370mg/1litre ; 3.68gram/1litre ; 300mg/1litre

Plasmalyte 148 + Glucose 5 % w/v Viaflo inf. sol. i.v. Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

plasmalyte 148 + glucose 5 % w/v viaflo inf. sol. i.v.

baxter sa-nv - sodium acetate trihydrate 3,68 g/l; potassium chloride 370 µg/ml; magnesium chloride hexahydrate 300 µg/ml; sodium gluconate 5,02 mg/ml; sodium chloride 5,26 mg/ml; glucose monohydrate 55 mg/ml - solution for infusion - glucose monohydrate 55 mg/ml; magnesium chloride hexahydrate 300 µg/ml; potassium chloride 370 µg/ml; sodium gluconate 5.02 mg/ml; sodium chloride 5.26 mg/ml; sodium acetate trihydrate - electrolytes with carbohydrates

Plasmalyte 148 + Glucose 5 % w/v Viaflo inf. sol. i.v. Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

plasmalyte 148 + glucose 5 % w/v viaflo inf. sol. i.v.

baxter sa-nv - sodium acetate trihydrate 3,68 g/l; potassium chloride 370 µg/ml; magnesium chloride hexahydrate 300 µg/ml; sodium gluconate 5,02 mg/ml; sodium chloride 5,26 mg/ml; glucose monohydrate 55 mg/ml - solution for infusion - electrolytes with carbohydrates

Plasmalyte 148 + Glucose 5 % w/v Viaflo inf. sol. i.v. Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

plasmalyte 148 + glucose 5 % w/v viaflo inf. sol. i.v.

baxter sa-nv - sodium acetate trihydrate 3,68 g/l; potassium chloride 370 µg/ml; magnesium chloride hexahydrate 300 µg/ml; sodium gluconate 5,02 mg/ml; sodium chloride 5,26 mg/ml; glucose monohydrate 55 mg/ml - solution for infusion - electrolytes with carbohydrates

GLUCOSE 5 % INTRAVENOUS INFUSION BP Israel - English - Ministry of Health

glucose 5 % intravenous infusion bp

teva medical marketing ltd. - glucose monohydrate - solution for infusion - glucose monohydrate 5.5 %w/v - glucose - glucose - glucose 5 % intravenous infusion is indicated for the treatment of carbohydrate and fluid depletion. glucose 5 % is also used as a vehicle and diluent for compatible medicinal products for parenteral administration.

GLUCOSE 5 % INTRAVENOUS INFUSION BP Israel - English - Ministry of Health

glucose 5 % intravenous infusion bp

teva medical marketing ltd. - glucose monohydrate - solution for infusion - glucose monohydrate 5.5 %w/v - glucose - glucose - glucose 5 % intravenous infusion is indicated for the treatment of carbohydrate and fluid depletion. glucose 5 % is also used as a vehicle and diluent for compatible medicinal products for parenteral administration.

GLUCOSE 5 % INTRAVENOUS INFUSION BP Israel - English - Ministry of Health

glucose 5 % intravenous infusion bp

teva medical marketing ltd. - glucose monohydrate - solution for infusion - glucose monohydrate 5.5 %w/v - glucose - glucose - for the treatment of carbohydrate and fluid depletion. glucose 5 % is also used as a vehicle and diluent for compatible medicinal products for parenteral administration.